Could Bitcoin Become a U.S. Strategic Reserve?by John Darbie 15.08.2024Exploring Bitcoin's potential as a U.S. strategic reserve amid growing institutional interest and political challenges.
PDS Biotech’s Q2 2024 Update: Clinical Progressby Lilu Anderson 13.08.2024PDS Biotech aligns with FDA for Phase 3 trial, reports Q2 2024 financials with reduced net loss and expenses.
Top Biotech Stocks to Watch: Expert Analysisby Lilu Anderson 13.08.2024Discover promising biotech stocks with expert insights on market trends and innovative drugmakers worth your investment.
Understanding the Risk of Social Unrest in Financeby Mark Eisenberg 12.08.2024Explore the financial factors contributing to potential social unrest and what it means for the economy and society.
Navy SEAL VR Experience at Navy Pierby Lilu Anderson 10.08.2024Explore Navy SEAL missions in VR during Navy Week at Navy Pier. High-speed thrills await with cutting-edge technology.
SoundHound AI Stock Levels Amid News Movesby Mark Eisenberg 09.08.2024SoundHound AI shares surge 21% after acquiring Amelia, but drop post earnings. Watch key price levels.
Analyst Backs ALGT and APT After DOGE Exit; AI-Driven Edgeby John Darbie 06.08.2024**Cryptocurrency Update: Analyst's Bold Move Post-DOGE Crash, Eyes Algotech & Aptos for High Returns**. Discover their investment strategy.
Financial Advisors Expand Billing Options; Asset-Based Fees Prevailby Mark Eisenberg 06.08.2024Financial advisors are now diversifying billing methods, yet asset-based fees endure. Cody Lachner's firm embraces both subscriptions and AUM.
Monday’s Market Plunge: Should Investors Be Worried?by Mark Eisenberg 06.08.2024Analyzing Monday's market drop: Is the sky truly falling? Unpack long-term investment strategies amid a 3% S&P 500 dip on ...
Clover Health Q2 2024: First Positive Net Income Achievedby Mark Eisenberg 06.08.2024Clover Health reports its first-ever positive net income in Q2 2024, driven by financial growth and a technology-driven care platform.